Online Program

327072
Understanding Treatment Decision Making Among Patients with Colorectal Cancer (CRC)


Monday, November 2, 2015

Nicole Cranley, M.S., Department of Behavioral Science and Community Health, University of Florida, Gainesville, FL
Barbara Curbow, PhD, School of Public Health; Department Of Behavioral and Community Health, University of Maryland - College Park, College Park, MD
Juliette Christie, PhD, Behavioral Science and Community Health, University of Florida, Gainesville, FL
Mary Ellen Young, PhD, Department of Behavioral Science and Community Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL
Thomas George Jr., MD, Department of Medicine, University of Florida, Gainesville, FL
For many patients, decision-making surrounding cancer treatment can be a confusing and complicated process that is undertaken during a time of heightened distress. For stage II or III colorectal cancer (CRC), the initial treatment, surgery for colon cancer and surgery plus radiation for rectal cancer, may be made with little need to engage actively in the decision-making process because it is the commonly accepted first step in treatment. However, following initial treatment, the decisions of whether to undergo adjuvant chemotherapy (AC) are more complex. There are various potential factors that are influencing patients’ treatment decision-making, which can lead to decreased uptake of recommended therapeutic options (i.e., AC). Thus, the three primary goals of this project are, (1) to gain a greater understanding of the primary informal caregiver’s influence on patient’s treatment decision-making, (2) to investigate sociodemographic disparities in CRC treatment decision-making, and (3) to better understand the relationship between the provider-patient dynamic and patient treatment decision making. This project has a prospective, longitudinal design that will employ mixed methodologies. Patients (n=60) will be followed over four total data collection points beginning pre-surgery to approximately 3-4 weeks into treatment (for those patients who ultimately seek treatment) for a total time of 3 months (ending in November 2015). Results from this study will help us gain a better understanding of how patients and families make medical decisions. This insight can then inform the development of effective treatment decision aids to help patients and caregivers make more informed decisions about their care.

Learning Areas:

Public health or related research
Social and behavioral sciences

Learning Objectives:
Identify sociodemographic differences in treatment decision making among patients with CRC, and the impact of provider-patient communication and the primary informal caregiver on treatment decision making.

Keyword(s): Cancer, Decision-Making

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have examined decision making within the colorectal cancer population at various levels of prevention. I have had sufficient academic training to conduct research in this area with this population.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.